Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bindarit dose-ranging pilot study for prevention of coronary stent restenosis
2008-004921-40Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bindarit in coronary stenosis and atherosclerosis (3 arms), sponsored by Angelini Pharma. Primary endpoint: In-segment late loss. Started Sep 2008; status: completed.
02
Drugs
bindarit
03
Conditions
coronary stenosisatherosclerosis
Beyond the preview
Go deeper on 2008-004921-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004921-40.